- Covance | Labcorp
BURLINGTON, N C -- (BUSINESS WIRE)--May 28, 2020-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that Covance, its drug development business, is expanding its technology ecosystem to accelerate the adoption of decentralized clinical trials, often referred to as
- Overview of Covance Clinical Research and Drug Discovery
Covance, now part of Labcorp Drug Development, is one of the world’s leading Clinical Research Organizations (CROs) They specialize in managing clinical trials, preclinical research, regulatory consulting, and laboratory testing—basically, everything needed to bring a drug from concept to consumer
- Fortrea - Wikipedia
The company traces its roots to Environmental Sciences Corporation, formed in 1968 It was known as Hazleton from 1972 to 1990, Corning Lab Services from 1990 to 1996, Covance from 1996 to 2021, and Labcorp Drug Development from 2021 to 2023
- Covance Inc. -- Company History
Covance Inc ranks second in size among contract biopharmaceutical research organizations in the United States, providing a wide range of integrated product development services worldwide to the pharmaceutical, biotechnology, and medical device industries
- Covance - LinkedIn
Covance Research Services Princeton, New Jersey 351,535 followers This page is no longer active Please follow us at Labcorp Drug Development About us
- Investigator Portal
The Investigator Portal provides essential resources and tools for investigators to manage their studies effectively
- Covance - 2025 Company Profile Team - Tracxn
Explore Covance's in-depth company profile, including funding details, key investors, competitors, and acquisitions
- Covance | CVD Stock Price, Company Overview News - Forbes
Covance, Inc provides drug development services to pharmaceutical, biotechnology and medical device industries
|